Generics manufacturer
Reshaping a generics portfolio around where tenders are won
A leading generics manufacturer wanted to know which products were holding the portfolio back and which deserved more investment.
- Portfolio review
- Each product was assessed against tender demand, award prices and competitive intensity across its markets.
- Clear choices
- We identified products to discontinue and others that could gain share after formulation or presentation changes.
- Market evidence
- Each recommendation was backed by award history and price trends, so the commercial and supply teams could act on it.
Results
+20%
Revenue from the optimised portfolio
+35%
Improvement in profit margin